beta-lactam antibiotic
Showing 1 - 25 of 6,392
Machine Learning Model for Beta-Lactam Drugs Related Acute
Active, not recruiting
- Acute Kidney Injury
- Beta-Lactam Antibiotic Toxicity (Diagnosis)
- Beta-Lactam Drugs
-
Jinan, Shandong, ChinaXiao Li，MD
Sep 8, 2022
Cystic Fibrosis, Cystic Fibrosis Pulmonary Exacerbation Trial (Beta-lactam antibiotic, Aminoglycoside)
Not yet recruiting
- Cystic Fibrosis
- Cystic Fibrosis Pulmonary Exacerbation
- Beta-lactam antibiotic
- Aminoglycoside
- (no location specified)
Sep 16, 2022
Beta-lactam Pharmacokinetics in Secondary Care
Completed
- Pharmacokinetics
- +2 more
- Beta-lactam antibiotic
-
London, United KingdomHammersmith Hospital
Aug 4, 2021
Surgical Site Infection, Beta-lactam Allergy Trial (cephalosporin, Second tier antibiotic (Vancomycin))
Not yet recruiting
- Surgical Site Infection
- Beta-lactam Allergy
- cephalosporin
- Second tier antibiotic (Vancomycin)
- (no location specified)
Feb 25, 2022
Healthy Volunteers Trial in London (Phenoxymethyl Penicillin, Microneedle array)
Completed
- Healthy Volunteers
- Phenoxymethyl Penicillin
- Microneedle array
-
London, United KingdomNIHR Imperial CRF
Dec 3, 2020
Sepsis Trial in France (continuous pivotal ßL-AB, intermittent pivotal ßL-AB, AG infusion most 1 dose)
Not yet recruiting
- Sepsis
- continuous pivotal βL-AB
- +3 more
-
Amiens, France
- +23 more
Feb 1, 2023
Beta-lactam Target Non-attainment Risk Score in Adult ICU
Not yet recruiting
- Infection, Bacterial
- +4 more
- (no location specified)
Sep 13, 2022
Beta-Lactams Dosing In Pneumonia in ICU in Patients Treated by
Recruiting
- Beta-lactam
- +3 more
-
Valenciennes, Nord, FranceCentre Hospitalier de Valenciennes
Apr 23, 2021
Beta-lactam Therapeutic Drug Monitoring Programs in Critically
Active, not recruiting
- Sepsis
- Critical Illness
-
Gainesville, Florida
- +2 more
Feb 15, 2022
Pneumonia Trial in Gainesville (Cefepime, Meropenem, or Piperacillin/Tazobactam)
Recruiting
- Pneumonia
- Cefepime, Meropenem, or Piperacillin/Tazobactam
-
Gainesville, FloridaUniversity of Florida
Feb 24, 2022
Bacterial Infections Trial in Adelaide (QPX2015, Placebo oral capsule)
Completed
- Bacterial Infections
- QPX2015
- Placebo oral capsule
-
Adelaide, South Australia, AustraliaCMAX
Oct 6, 2022
Beta-lactam Therapeutic Drug Monitoring in Singapore
Recruiting
- Infection, Bacterial
- Beta-lactam Therapeutic Drug Monitoring
-
Singapore, SingaporeSingapore General Hospital
Apr 9, 2021
Adjunctive Clindamycin Versus Linezolid for ß-lactam Treated
Active, not recruiting
- Streptococcal Sepsis
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center (primary center co
Nov 8, 2023
Cross-allergies Between Cefazolin and Amoxicillin With Skin
Recruiting
- Allergic Reaction
- Beta Lactam Adverse Reaction
-
Paris, FranceGroupe Hospitalier Paris Saint-Joseph
Nov 7, 2022
Beta Lactam Resistant Bacterial Infection, Enterobacteriaceae Infections, Bacteremia Trial in Israel (Piperacillin / Tazobactam
Recruiting
- Beta Lactam Resistant Bacterial Infection
- +2 more
- Piperacillin / Tazobactam Injection
- Meropenem
-
Haifa, Israel
- +3 more
Jul 25, 2022
Determining Optimal Beta-lactam Plasma Concentrations Through
Recruiting
- Beta-lactam Antibiotics
- +10 more
- The study is observational.
-
Geneva, SwitzerlandGeneva University Hospitals
May 25, 2021
COPD Exacerbation Acute Trial in H?i Phòng (Beta-Lactams, Fluoroquinolone)
Completed
- COPD Exacerbation Acute
-
Hải Phòng, VietnamHaiphong International Hospital
May 4, 2021
Beta Lactam Resistant Bacterial Infection, Enterobacteriaceae Infections, Bacteremia Trial in Canada, Israel
Recruiting
- Beta Lactam Resistant Bacterial Infection
- +2 more
-
Montreal, Quebec, Canada
- +7 more
Jul 25, 2022
Sepsis Trial in Worldwide (Continuous infusion, Intermittent infusion)
Recruiting
- Sepsis
- Continuous infusion
- Intermittent infusion
-
Bankstown, New South Wales, Australia
- +105 more
Sep 26, 2021
Buruli Ulcer Trial in Allada, Lalo, Pobè (Standard [RC8]: rifampicin plus clarithromycin (RC) therapy for 8 weeks.,
Recruiting
- Buruli Ulcer
- Standard [RC8]: rifampicin plus clarithromycin (RC) therapy for 8 weeks.
- Investigational [RCA4]: standard (RC) plus amoxicillin/clavulanate (A) for 4 weeks.
-
Allada, Benin
- +2 more
Dec 22, 2021
Infection, Liver Dysfunction, Urinary Tract Infection Trial in Bruxelles (Temocillin)
Recruiting
- Infection
- +2 more
-
Bruxelles, BelgiumCliniques universitaires St-Luc
May 24, 2022
Infections Trial in Ghent (device, diagnostic test, other)
Not yet recruiting
- Infections
- Prediction of plasma concentration of piperacillin-tazobactam or meropenem
- +2 more
-
Ghent, BelgiumUniversity Hospital, Ghent
Sep 4, 2023
Enterobacteriaceae Infections Trial in Spain (Antipseudomonal beta-lactam antibiotic, De-escalation(short-spectrum antibiotic))
Completed
- Enterobacteriaceae Infections
- Antipseudomonal beta-lactam antibiotic
- De-escalation(short-spectrum antibiotic)
-
Jerez de la Frontera, Cádiz, Spain
- +20 more
Jul 15, 2020
Drug Hypersensitivity Trial in Montpellier (simplified drug provocation test)
Completed
- Drug Hypersensitivity
- simplified drug provocation test
-
Montpellier, FranceUniversity hospital of Montpellier
Dec 30, 2021
Gram-negative Bacteremia Trial (De-escalation VS No De-escalation, Oral beta-lactams VS non beta-lactams, Central vascular
Not yet recruiting
- Gram-negative Bacteremia
- De-escalation VS No De-escalation
- +4 more
- (no location specified)
May 30, 2023